ArticleBreast cancer research and treatment2026
Anthracycline-containing versus anthracycline-free carboplatin-based regimens in early-stage triple-negative breast cancer: real-world outcomes.
Matthew R Kroll et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.